Apotex Launches Pre-Emptive Strike Against Par

Law360, New York (March 15, 2006, 12:00 AM EST) -- A patent squabble has erupted between two generic drug makers, as Apotex Inc. has slapped Par Pharmaceuticals with a lawsuit in hopes of blocking the company from suing it over a generic version of appetite stimulant Megace.

Apotex filed the lawsuit in U.S. District Court for the District of New Jersey last Friday, requesting that the court issue a declaratory judgment regarding four patents held by Par.

The intellectual property covers a generic version of Megace, known as megestrol acetate oral suspension, in addition to the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.